Seller record · Telehealth service

Evolve Telemed

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 4 of 8 criteria. S3, pharmacy identification: No pharmacy is named. The terms and the answers refer only to partner compounding pharmacies that compound and ship each order. 3 more criteria also fail; see the table below.

At a glance

Evolve TelemedTelehealth service

4/8criteria passed

Price: Not printed before a consultation or sign-up
Sells: semaglutide injection with cyanocobalamin, and 5 more
FDA letters: None on file

Visit Evolve Telemed See all eight dispositions

Telehealth service. Passes 4 of 8 criteria. Recorded against Standard v1.1.

A Michigan telemedicine platform for hormone and peptide therapy whose independent providers prescribe compounded semaglutide and tirzepatide injections, tesamorelin, PT-141, GHK-Cu and SS-31 after a free virtual consultation and lab work.

Operating entity E-Volve Company, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Evolve Telemed's website; Evolve Telemed's terms and conditions; Evolve Telemed's about page
S2	Prescription gating	PASS	Evolve Telemed's website; Evolve Telemed's semaglutide product page
S3	Pharmacy identification	FAIL	Evolve Telemed's terms and conditions; Evolve Telemed's frequently asked questions FAQ
S4	Compounding disclosure	FAIL	Evolve Telemed's terms and conditions; Evolve Telemed's PT-141 product page; Evolve Telemed's semaglutide product page
S5	Analytical documentation	FAIL	Evolve Telemed's semaglutide product page; Evolve Telemed's frequently asked questions FAQ; Evolve Telemed's terms and conditions
S6	Business address	PASS	Evolve Telemed's website; Evolve Telemed's terms and conditions
S7	Price disclosure	FAIL	Evolve Telemed's frequently asked questions FAQ; Evolve Telemed's semaglutide product page; Evolve Telemed's tirzepatide product page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSBoard-certified providers meet each patient virtually and review lab results before building a treatment plan, and the terms say all clinical services come from independent licensed providers, not the company.Source: Evolve Telemed's website; Evolve Telemed's terms and conditions; Evolve Telemed's about page.

S2PASSEvery start button books a free virtual consultation with a provider, followed by a lab panel and a review of the results, before any treatment plan or order.Source: Evolve Telemed's website; Evolve Telemed's semaglutide product page.

S3FAILNo pharmacy is named. The terms and the answers refer only to partner compounding pharmacies that compound and ship each order.Source: Evolve Telemed's terms and conditions; Evolve Telemed's frequently asked questions FAQ.

S4FAILThe terms say partner pharmacies compound all treatments, but no page states that compounded medications are not FDA-approved, and the PT-141 nasal spray page calls the product an FDA approved therapy.Source: Evolve Telemed's terms and conditions; Evolve Telemed's PT-141 product page; Evolve Telemed's semaglutide product page.

S5FAILNo certificate of analysis or lot document is published on the treatment pages, the answers or the terms.Source: Evolve Telemed's semaglutide product page; Evolve Telemed's frequently asked questions FAQ; Evolve Telemed's terms and conditions.

S6PASSEvolve Telemedicine at 43313 Woodward Ave #1394, Bloomfield Hills, MI 48302, printed in the footer of every page and in the terms, which name E-Volve Company, Inc.Source: Evolve Telemed's website; Evolve Telemed's terms and conditions.

S7FAILNo price is printed for semaglutide, tirzepatide or any peptide. The answers say costs vary by plan and that a hormone optimization plan starts at around $75 a month.Source: Evolve Telemed's frequently asked questions FAQ; Evolve Telemed's semaglutide product page; Evolve Telemed's tirzepatide product page.

S8PASSNo FDA warning letter names Evolve Telemed, Evolve Telemedicine or E-Volve Company, Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide injection with cyanocobalamin, tirzepatide injection with niacinamide, tesamorelin, PT-141 nasal spray, GHK-Cu, SS-31.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells PT-141 Who sells GHK-Cu Who sells tesamorelin

Visit Evolve Telemed

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.